SCHEMBL20186692

SCHEMBL20186692

C#CCCC1c2c(c3cc(Cl)ccc3n2[Si](C)(C)C(C)(C)C)CCN1S(=O)(=O)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 2/20 0.34
▸ TERT O14746 1/20 0.34
▸ PSEN1 P49768 2/20 0.33
▸ PSEN2 P49810 2/20 0.33
▸ APH1B Q8WW43 2/20 0.33
▸ NCSTN Q92542 2/20 0.33
▸ APH1A Q96BI3 2/20 0.33
▸ PSENEN Q9NZ42 2/20 0.33
▸ ACHE P22303 1/20 0.33
▸ MMP1 P03956 1/20 0.33
▸ MMP2 P08253 1/20 0.33
▸ MMP7 P09237 1/20 0.33
▸ MMP9 P14780 1/20 0.33
▸ MMP12 P39900 1/20 0.33
▸ MMP14 P50281 1/20 0.33
▸ MMP15 P51511 1/20 0.33
▸ MMP16 P51512 1/20 0.33
▸ MMP26 Q9NRE1 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.32
▸ HTR6 P50406 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20186647 0.91 HTR6 (0.37) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL20186813 0.89 LMNA (0.38) HSD11B1HTR6MAPTSMN1; SMN2MMP8
SCHEMBL20186640 0.89 NOD1 (0.36) HSD11B1ACHEMMP2ALDH1A1TDP1
SCHEMBL20186463 0.86 HTR6 (0.36) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL18201257 0.65 ABCB1 (0.35) —
SCHEMBL7122701 0.58 ACHE (0.65) HSD11B1ACHEMMP2ALDH1A1TDP1
SCHEMBL14738049 0.58 ACHE (0.65) HSD11B1ACHEMMP2ALDH1A1TDP1
SCHEMBL30558751 0.56 CA1 (0.49) HSD11B1ACHEMMP1MMP2MMP9
SCHEMBL1571372 0.56 ALDH1A1 (0.68) TERTPSEN1PSEN2APH1BNCSTN
SCHEMBL16802348 0.55 ACHE (0.69) HSD11B1PSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3288921-B1 POLYCYCLIC INDOLINE AND INDOLENINE COMPOUNDS UNIV COLORADO REGENTS (US) 2022-06-15 — — EP disclosed
US-10253024-B2 Polycyclic indoline and indolenine compounds THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2019-04-09 — — US disclosed
US-20180148442-A1 Polycyclic Indoline and Indolenine Compounds THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2018-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10253024-B2 Polycyclic indoline and indolenine compounds IDO1, IDO2, INMT HSD11B1 1868/4885TERT 2761/4885PSEN1 755/4885
US-20180148442-A1 Polycyclic Indoline and Indolenine Compounds IDO1, IDO2, INMT HSD11B1 1868/4885TERT 2761/4885PSEN1 755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback